{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:36:05Z","timestamp":1773707765024,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,7,2]],"date-time":"2008-07-02T00:00:00Z","timestamp":1214956800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1007\/s10875-008-9217-0","type":"journal-article","created":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T21:56:39Z","timestamp":1214949399000},"page":"38-45","source":"Crossref","is-referenced-by-count":30,"title":["Interleukin-18 Binding Protein in the Sera of Patients with Wegener\u2019s Granulomatosis"],"prefix":"10.1007","volume":"29","author":[{"given":"D.","family":"Novick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Elbirt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. A.","family":"Dinarello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rubinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z. M.","family":"Sthoeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,7,2]]},"reference":[{"key":"9217_CR1","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","volume":"116","author":"GS Hoffman","year":"1992","unstructured":"Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488\u201398.","journal-title":"Ann Intern Med"},{"key":"9217_CR2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/art.1780390112","volume":"39","author":"MF Cotch","year":"1996","unstructured":"Cotch MF, Hoffman GS, Yerg DE, Kaufman GI, Targonski P, Kaslow RA. The epidemiology of Wegener\u2019s granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum 1996;39:87\u201392. doi: 10.1002\/art.1780390112 .","journal-title":"Arthritis Rheum"},{"key":"9217_CR3","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/art.11075","volume":"48","author":"JH Stone","year":"2003","unstructured":"Stone JH. Limited versus severe Wegener\u2019s granulomatosis: baseline data on patients in the Wegener\u2019s granulomatosis etanercept trial. Arthritis Rheum 2003;48:2299\u2013309. doi: 10.1002\/art.11075 .","journal-title":"Arthritis Rheum"},{"key":"9217_CR4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/ncprheum0139","volume":"2","author":"PK Wung","year":"2006","unstructured":"Wung PK, Stone JH. Therapeutics of Wegener\u2019s granulomatosis. Nat Clin Pract Rheumatol 2006;2:192\u2013200. doi: 10.1038\/ncprheum0139 .","journal-title":"Nat Clin Pract Rheumatol"},{"key":"9217_CR5","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O","volume":"43","author":"MM Boomsma","year":"2000","unstructured":"Boomsma MM, Stegeman CA, van der Leij MJ, Oost W, Hermans J, Kallenberg CG, et al. Prediction of relapses in Wegener\u2019s granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study. Arthritis Rheum 2000;43:2025\u201333. doi: 10.1002\/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O .","journal-title":"Arthritis Rheum"},{"key":"9217_CR6","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/S0002-9440(10)61118-2","volume":"160","author":"A Komocsi","year":"2002","unstructured":"Komocsi A, Lamprecht P, Csernok E, Mueller A, Holl-Ulrich K, Seitzer U, et al. Peripheral blood and granuloma CD4(+)CD28(\u2212) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener\u2019s granulomatosis. Am J Pathol 2002;160:1717\u201324.","journal-title":"Am J Pathol"},{"key":"9217_CR7","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/1529-0131(199904)42:4<742::AID-ANR18>3.0.CO;2-I","volume":"42","author":"E Csernok","year":"1999","unstructured":"Csernok E, Trabandt A, Muller A, Wang GC, Moosig F, Paulsen J, et al. Cytokine profiles in Wegener\u2019s granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation. Arthritis Rheum 1999;42:742\u201350. doi: 10.1002\/1529-0131(199904)42:4<742::AID-ANR18>3.0.CO;2-I .","journal-title":"Arthritis Rheum"},{"key":"9217_CR8","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.4049\/jimmunol.160.7.3602","volume":"160","author":"BR Ludviksson","year":"1998","unstructured":"Ludviksson BR, Sneller MC, Chua KS, Talar-Williams C, Langford CA, Ehrhardt RO, et al. Active Wegener\u2019s granulomatosis is associated with HLA-DR+ CD4+ T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10. J Immunol 1998;160:3602\u20139.","journal-title":"J Immunol"},{"key":"9217_CR9","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-2249.2005.02770.x","volume":"140","author":"EA Torheim","year":"2005","unstructured":"Torheim EA, Yndestad A, Bjerkeli V, Halvorsen B, Aukrust P, Froland SS. Increased expression of chemokines in patients with Wegener\u2019s granulomatosis\u2014modulating effects of methylprednisolone in vitro. Clin Exp Immunol 2005;140:376\u201383. doi: 10.1111\/j.1365-2249.2005.02770.x .","journal-title":"Clin Exp Immunol"},{"issue":"Suppl 4","key":"9217_CR10","doi-asserted-by":"crossref","first-page":"iv31","DOI":"10.1136\/ard.2005.042416","volume":"64","author":"C Mukhtyar","year":"2005","unstructured":"Mukhtyar C, Luqmani R. Current state of tumour necrosis factor {alpha} blockade in Wegener\u2019s granulomatosis. Ann Rheum Dis 2005;64(Suppl 4):iv31\u20136. doi: 10.1136\/ard.2005.042416 .","journal-title":"Ann Rheum Dis"},{"key":"9217_CR11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/378088a0","volume":"378","author":"H Okamura","year":"1995","unstructured":"Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995;378:88\u201391. doi: 10.1038\/378088a0 .","journal-title":"Nature"},{"key":"9217_CR12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0065-2776(08)60389-2","volume":"70","author":"H Okamura","year":"1998","unstructured":"Okamura H, Tsutsui H, Kashiwamura S, Yoshimoto T, Nakanishi K. Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv Immunol 1998;70:281\u2013312. doi: 10.1016\/S0065-2776(08)60389-2 .","journal-title":"Adv Immunol"},{"key":"9217_CR13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1189\/jlb.0602313","volume":"73","author":"JA Gracie","year":"2003","unstructured":"Gracie JA, Robertson SE, McInnes IB. Interleukin-18. J Leukoc Biol 2003;73:213\u201324. doi: 10.1189\/jlb.0602313 .","journal-title":"J Leukoc Biol"},{"key":"9217_CR14","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/IAI.57.2.590-595.1989","volume":"57","author":"K Nakamura","year":"1989","unstructured":"Nakamura K, Okamura H, Wada M, Nagata K, Tamura T. Endotoxin-induced serum factor that stimulates gamma interferon production. Infect Immun 1989;57:590\u20135.","journal-title":"Infect Immun"},{"key":"9217_CR15","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4049\/jimmunol.177.1.234","volume":"177","author":"JR Maxwell","year":"2006","unstructured":"Maxwell JR, Yadav R, Rossi RJ, Ruby CE, Weinberg AD, Aguila HL, et al. IL-18 bridges innate and adaptive immunity through IFN-gamma and the CD134 pathway. J Immunol 2006;177:234\u201345.","journal-title":"J Immunol"},{"key":"9217_CR16","doi-asserted-by":"crossref","first-page":"25737","DOI":"10.1074\/jbc.272.41.25737","volume":"272","author":"K Torigoe","year":"1997","unstructured":"Torigoe K, Ushio S, Okura T, Kobayashi S, Taniai M, Kunikata T, et al. Purification and characterization of the human interleukin-18 receptor. J Biol Chem 1997;272:25737\u201342. doi: 10.1074\/jbc.272.41.25737 .","journal-title":"J Biol Chem"},{"key":"9217_CR17","doi-asserted-by":"crossref","first-page":"29445","DOI":"10.1074\/jbc.273.45.29445","volume":"273","author":"TL Born","year":"1998","unstructured":"Born TL, Thomassen E, Bird TA, Sims JE. Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. J Biol Chem 1998;273:29445\u201350. doi: 10.1074\/jbc.273.45.29445 .","journal-title":"J Biol Chem"},{"key":"9217_CR18","first-page":"224","volume":"17","author":"D Boraschi","year":"2006","unstructured":"Boraschi D, Dinarello CA. IL-18 in autoimmunity. Eur Cytokine Netw 2006;17:224\u201352.","journal-title":"Eur Cytokine Netw"},{"key":"9217_CR19","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/rheumatology\/39.10.1078","volume":"39","author":"CK Wong","year":"2000","unstructured":"Wong CK, Li EK, Ho CY, Lam CW. Elevation of plasma interleukin-18 concentration is correlated with disease activity in systemic lupus erythematosus. Rheumatology (Oxford) 2000;39:1078\u201381. doi: 10.1093\/rheumatology\/39.10.1078 .","journal-title":"Rheumatology (Oxford)"},{"key":"9217_CR20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1074-7613(00)80013-8","volume":"10","author":"D Novick","year":"1999","unstructured":"Novick D, Kim SH, Fantuzzi G, Reznikov LL, Dinarello CA, Rubinstein M. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 1999;10:127\u201336. doi: 10.1016\/S1074-7613(00)80013-8 .","journal-title":"Immunity"},{"key":"9217_CR21","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1073\/pnas.97.3.1190","volume":"97","author":"SH Kim","year":"2000","unstructured":"Kim SH, Eisenstein M, Reznikov L, Fantuzzi G, Novick D, Rubinstein M, et al. Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. Proc Natl Acad Sci U S A 2000;97:1190\u20135. doi: 10.1073\/pnas.97.3.1190 .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9217_CR22","doi-asserted-by":"crossref","first-page":"16957","DOI":"10.1073\/pnas.262663399","volume":"99","author":"V Hurgin","year":"2002","unstructured":"Hurgin V, Novick D, Rubinstein M. The promoter of IL-18 binding protein: activation by an IFN-gamma -induced complex of IFN regulatory factor 1 and CCAAT\/enhancer binding protein beta. Proc Natl Acad Sci U S A 2002;99:16957\u201362. doi: 10.1073\/pnas.262663399 .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9217_CR23","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/cyto.2001.0914","volume":"14","author":"D Novick","year":"2001","unstructured":"Novick D, Schwartsburd B, Pinkus R, Suissa D, Belzer I, Sthoeger Z, et al. A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. Cytokine 2001;14:334\u201342. doi: 10.1006\/cyto.2001.0914 .","journal-title":"Cytokine"},{"key":"9217_CR24","first-page":"27","volume":"16","author":"O Ludwiczek","year":"2005","unstructured":"Ludwiczek O, Kaser A, Novick D, Dinarello CA, Rubinstein M, Tilg H. Elevated systemic levels of free interleukin-18 (IL-18) in patients with Crohn\u2019s disease. Eur Cytokine Netw 2005;16:27\u201333.","journal-title":"Eur Cytokine Netw"},{"key":"9217_CR25","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1046\/j.1365-2249.2002.01911.x","volume":"129","author":"A Kaser","year":"2002","unstructured":"Kaser A, Novick D, Rubinstein M, Siegmund B, Enrich B, Koch RO, et al. Interferon-alpha induces interleukin-18 binding protein in chronic hepatitis C patients. Clin Exp Immunol 2002;129:332\u20138. doi: 10.1046\/j.1365-2249.2002.01911.x .","journal-title":"Clin Exp Immunol"},{"key":"9217_CR26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/ibd.20272","volume":"14","author":"ST Leach","year":"2008","unstructured":"Leach ST, Messina I, Lemberg DA, Novick D, Rubenstein M, Day AS. Local and systemic interleukin-18 and interleukin-18-binding protein in children with inflammatory bowel disease. Inflamm Bowel Dis 2008;14:68\u201374. doi: 10.1002\/ibd.20272 .","journal-title":"Inflamm Bowel Dis"},{"key":"9217_CR27","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","volume":"33","author":"RY Leavitt","year":"1990","unstructured":"Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener\u2019s granulomatosis. Arthritis Rheum 1990;33:1101\u20137.","journal-title":"Arthritis Rheum"},{"key":"9217_CR28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","volume":"37","author":"JC Jennette","year":"1994","unstructured":"Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187\u201392. doi: 10.1002\/art.1780370206 .","journal-title":"Arthritis Rheum"},{"key":"9217_CR29","first-page":"671","volume":"87","author":"RA Luqmani","year":"1994","unstructured":"Luqmani RA, Bacon PA, Beaman M, Scott DG, Emery P, Lee SJ, et al. Classical versus non-renal Wegener\u2019s granulomatosis. Q J Med 1994;87:671\u20138.","journal-title":"Q J Med"},{"key":"9217_CR30","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0956-5663(95)96925-O","volume":"10","author":"DL Gatto-Menking","year":"1995","unstructured":"Gatto-Menking DL, Yu H, Bruno JG, Goode MT, Miller M, Zulich AW. Sensitive detection of biotoxoids and bacterial spores using an immunomagnetic electrochemiluminescence sensor. Biosens Bioelectron 1995;10:501\u20137. doi: 10.1016\/0956-5663(95)96925-O .","journal-title":"Biosens Bioelectron"},{"key":"9217_CR31","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1172\/JCI1379","volume":"101","author":"AJ Puren","year":"1998","unstructured":"Puren AJ, Fantuzzi G, Gu Y, Su MS, Dinarello CA. Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells. J Clin Invest 1998;101:711\u201321. doi: 10.1172\/JCI1379 .","journal-title":"J Clin Invest"},{"key":"9217_CR32","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5","volume":"44","author":"JH Stone","year":"2001","unstructured":"Stone JH, Hoffman GS, Merkel PA, Min YI, Uhlfelder ML, Hellmann DB, et al. A disease-specific activity index for Wegener\u2019s granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis Rheum 2001;44:912\u201320. doi: 10.1002\/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5 .","journal-title":"Arthritis Rheum"},{"key":"9217_CR33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1479-666X(06)80021-1","volume":"4","author":"AM Khan","year":"2006","unstructured":"Khan AM, Elahi F, Hashmi SR, Mahida KH, Ingrams DR. Wegener\u2019s granulomatosis: a rare, chronic and multisystem disease. Surgeon 2006;4:45\u201352.","journal-title":"Surgeon"},{"key":"9217_CR34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1365-2249.2002.01801.x","volume":"128","author":"P Lamprecht","year":"2002","unstructured":"Lamprecht P, Kumanovics G, Mueller A, Csernok E, Komocsi A, Trabandt A, et al. Elevated monocytic IL-12 and TNF-alpha production in Wegener\u2019s granulomatosis is normalized by cyclophosphamide and corticosteroid therapy. Clin Exp Immunol 2002;128:181\u20136. doi: 10.1046\/j.1365-2249.2002.01801.x .","journal-title":"Clin Exp Immunol"},{"key":"9217_CR35","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1034\/j.1600-0463.2001.d01-146.x","volume":"109","author":"O Jonasdottir","year":"2001","unstructured":"Jonasdottir O, Petersen J, Bendtzen K. Tumour necrosis factor-alpha (TNF), lymphotoxin and TNF receptor levels in serum from patients with Wegener\u2019s granulomatosis. APMIS 2001;109:781\u20136. doi: 10.1034\/j.1600-0463.2001.d01-146.x .","journal-title":"APMIS"},{"key":"9217_CR36","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/sj.ki.5000167","volume":"69","author":"P Hewins","year":"2006","unstructured":"Hewins P, Morgan MD, Holden N, Neil D, Williams JM, Savage CO, et al. IL-18 is upregulated in the kidney and primes neutrophil responsiveness in ANCA-associated vasculitis. Kidney Int 2006;69:605\u201315. doi: 10.1038\/sj.ki.5000167 .","journal-title":"Kidney Int"},{"key":"9217_CR37","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/08916930701622783","volume":"40","author":"O Hultgren","year":"2007","unstructured":"Hultgren O, Andersson B, Hahn-Zoric M, Almroth G. Serum concentration of interleukin-18 is up-regulated in patients with ANCA-associated vasculitis. Autoimmunity 2007;40:529\u201331. doi: 10.1080\/08916930701622783 .","journal-title":"Autoimmunity"},{"key":"9217_CR38","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1172\/JCI200112097","volume":"108","author":"C Plater-Zyberk","year":"2001","unstructured":"Plater-Zyberk C, Joosten LA, Helsen MM, Sattonnet-Roche P, Siegfried C, Alouani S, et al. Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis. J Clin Invest 2001;108:1825\u201332.","journal-title":"J Clin Invest"},{"key":"9217_CR39","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/art.20014","volume":"50","author":"L Tissi","year":"2004","unstructured":"Tissi L, McRae B, Ghayur T, von Hunolstein C, Orefici G, Bistoni F, et al. Role of interleukin-18 in experimental group B streptococcal arthritis. Arthritis Rheum 2004;50:2005\u201313. doi: 10.1002\/art.20014 .","journal-title":"Arthritis Rheum"},{"key":"9217_CR40","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1212\/WNL.59.2.287","volume":"59","author":"S Jander","year":"2002","unstructured":"Jander S, Stoll G. Increased serum levels of the interferon-gamma-inducing cytokine interleukin-18 in myasthenia gravis. Neurology 2002;59:287\u20139.","journal-title":"Neurology"},{"key":"9217_CR41","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2249.2005.02661.x","volume":"139","author":"H Lettesjo","year":"2005","unstructured":"Lettesjo H, Hansson T, Bergqvist A, Gronlund J, Dannaeus A. Enhanced interleukin-18 levels in the peripheral blood of children with coeliac disease. Clin Exp Immunol 2005;139:138\u201343. doi: 10.1111\/j.1365-2249.2005.02661.x .","journal-title":"Clin Exp Immunol"},{"key":"9217_CR42","first-page":"131","volume":"22","author":"SH Kim","year":"2005","unstructured":"Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA. Interleukin-32: a cytokine and inducer of TNF alpha. Immunity 2005;22:131\u201342.","journal-title":"Immunity"},{"issue":"Suppl 3","key":"9217_CR43","doi-asserted-by":"crossref","first-page":"iii61","DOI":"10.1136\/ard.2006.058511","volume":"65","author":"CA Dinarello","year":"2006","unstructured":"Dinarello CA, Kim SH. IL-32, a novel cytokine with a possible role in disease. Ann Rheum Dis 2006;65(Suppl 3):iii61\u20134. doi: 10.1136\/ard.2006.058511 .","journal-title":"Ann Rheum Dis"},{"key":"9217_CR44","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1073\/pnas.0511206103","volume":"103","author":"D Novick","year":"2006","unstructured":"Novick D, Rubinstein M, Azam T, Rabinkov A, Dinarello CA, Kim SH. Proteinase 3 is an IL-32 binding protein. Proc Natl Acad Sci U S A 2006;103:3316\u201321. doi: 10.1073\/pnas.0511206103 .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9217_CR45","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1196\/annals.1423.028","volume":"1110","author":"P Lamprecht","year":"2007","unstructured":"Lamprecht P, Till A, Steinmann J, Aries PM, Gross WL. Current state of biologicals in the management of systemic vasculitis. Ann N Y Acad Sci 2007;1110:261\u201370. doi: 10.1196\/annals.1423.028 .","journal-title":"Ann N Y Acad Sci"},{"key":"9217_CR46","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1186\/ar2074","volume":"8","author":"H Shoda","year":"2006","unstructured":"Shoda H, Fujio K, Yamaguchi Y, Okamoto A, Sawada T, Kochi Y, et al. Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases. Arthritis Res Ther 2006;8:R166. doi: 10.1186\/ar2074 .","journal-title":"Arthritis Res Ther"},{"key":"9217_CR47","doi-asserted-by":"crossref","first-page":"16309","DOI":"10.1073\/pnas.0508237102","volume":"102","author":"MG Netea","year":"2005","unstructured":"Netea MG, Azam T, Ferwerda G, Girardin SE, Walsh M, Park JS, et al. IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc Natl Acad Sci U S A 2005;102:16309\u201314. doi: 10.1073\/pnas.0508237102 .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9217_CR48","doi-asserted-by":"crossref","first-page":"7038","DOI":"10.4049\/jimmunol.167.12.7038","volume":"167","author":"J Paulukat","year":"2001","unstructured":"Paulukat J, Bosmann M, Nold M, Garkisch S, Kampfer H, Frank S, et al. Expression and release of IL-18 binding protein in response to IFN-gamma. J Immunol 2001;167:7038\u201343.","journal-title":"J Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-008-9217-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-008-9217-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-008-9217-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T22:32:30Z","timestamp":1738276350000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-008-9217-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,2]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["9217"],"URL":"https:\/\/doi.org\/10.1007\/s10875-008-9217-0","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,2]]}}}